Letter | Published:

m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways

Nature volume 548, pages 338342 (17 August 2017) | Download Citation


N6-methyladenosine (m6A) is the most common and abundant messenger RNA modification, modulated by ‘writers’, ‘erasers’ and ‘readers’ of this mark1,2. In vitro data have shown that m6A influences all fundamental aspects of mRNA metabolism, mainly mRNA stability, to determine stem cell fates3,4. However, its in vivo physiological function in mammals and adult mammalian cells is still unknown. Here we show that the deletion of m6A ‘writer’ protein METTL3 in mouse T cells disrupts T cell homeostasis and differentiation. In a lymphopaenic mouse adoptive transfer model, naive Mettl3-deficient T cells failed to undergo homeostatic expansion and remained in the naive state for up to 12 weeks, thereby preventing colitis. Consistent with these observations, the mRNAs of SOCS family genes encoding the STAT signalling inhibitory proteins SOCS1, SOCS3 and CISH were marked by m6A, exhibited slower mRNA decay and showed increased mRNAs and levels of protein expression in Mettl3-deficient naive T cells. This increased SOCS family activity consequently inhibited IL-7-mediated STAT5 activation and T cell homeostatic proliferation and differentiation. We also found that m6A has important roles for inducible degradation of Socs mRNAs in response to IL-7 signalling in order to reprogram naive T cells for proliferation and differentiation. Our study elucidates for the first time, to our knowledge, the in vivo biological role of m6A modification in T-cell-mediated pathogenesis and reveals a novel mechanism of T cell homeostasis and signal-dependent induction of mRNA degradation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


Primary accessions

Gene Expression Omnibus


  1. 1.

    , , & Recent advances in dynamic m6A RNA modification. Open Biol. 6, 160003 (2016)

  2. 2.

    , , & Gene expression regulation mediated through reversible m6A RNA methylation. Nat. Rev. Genet. 15, 293–306 (2014)

  3. 3.

    et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science 347, 1002–1006 (2015)

  4. 4.

    et al. m6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15, 707–719 (2014)

  5. 5.

    & Selection and lineage specification in the thymus: commitment 4-stalled. Immunity 23, 4–5 (2005)

  6. 6.

    et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514–518 (2011)

  7. 7.

    et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G135–G146 (2009)

  8. 8.

    , , , & Homeostatic proliferation of mature T cells. Methods Mol. Biol. 979, 81–106 (2013)

  9. 9.

    & Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9, 823–832 (2009)

  10. 10.

    & Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat. Immunol. 12, 478–484 (2011)

  11. 11.

    , & SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454–465 (2007)

  12. 12.

    & Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol. 30, 592–602 (2009)

  13. 13.

    & Homeostasis of naive and memory T cells. Immunity 29, 848–862 (2008)

  14. 14.

    et al. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity 18, 475–487 (2003)

  15. 15.

    , & Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3, 460–465 (2001)

  16. 16.

    et al. A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J. Exp. Med. 197, 425–436 (2003)

  17. 17.

    et al. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell. Biol. 19, 6396–6407 (1999)

  18. 18.

    , & , RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 29, 1343–1355 (2015)

  19. 19.

    et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Reports 8, 284–296 (2014)

  20. 20.

    & Genome-wide technology for determining RNA stability in mammalian cells: historical perspective and recent advantages based on modified nucleotide labeling. RNA Biol. 9, 1233–1238 (2012)

  21. 21.

    et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat. Biotechnol. 29, 436–442 (2011)

  22. 22.

    et al. High-resolution sequencing and modeling identifies distinct dynamic RNA regulatory strategies. Cell 159, 1698–1710 (2014)

  23. 23.

    et al. Tracking distinct RNA populations using efficient and reversible covalent chemistry. Mol. Cell 59, 858–866 (2015)

  24. 24.

    et al. Generation of genetically modified mice using the CRISPR–Cas9 genome-editing system. Cold Spring Harb. Protoc. (2016)

  25. 25.

    et al. TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221–225 (2015)

  26. 26.

    et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013)

  27. 27.

    et al. Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010)

  28. 28.

    , , & WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41, W77–W83 (2013)

  29. 29.

    ggplot2: elegant graphics for data analysis. (2009)

  30. 30.

    et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-seq data. Proc. Natl Acad. Sci. USA 111, E5593–E5601 (2014)

  31. 31.

    & Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCt Method. Methods 25, 402–408 (2001)

  32. 32.

    , , , & Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencing. Nat. Protocols 8, 176–189 (2013)

  33. 33.

    et al. Model-based analysis of ChIP-seq (MACS). Genome Biol. 9, R137 (2008)

  34. 34.

    et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011)

  35. 35.

    & Structural insights into the molecular mechanism of the m6A writer complex. eLife 5, e18434 (2016)

  36. 36.

    , , & Induction of sporulation in Saccharomyces cerevisiae leads to the formation of N6-methyladenosine in mRNA: a potential mechanism for the activity of the IME4 gene. Nucleic Acids Res. 30, 4509–4518 (2002)

  37. 37.

    , & Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol. Cell 63, 306–317 (2016)

  38. 38.

    & Enriching s4U-RNA using methane thiosulfonate (MTS) chemistry. Curr. Protoc. Chem. Biol. 8, 234–250 (2016)

  39. 39.

    et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res. 43, D670–D681 (2015)

  40. 40.

    et al. Ensembl Genomes: an integrative resource for genome-scale data from non-vertebrate species. Nucleic Acids Res. 40, D91–D97 (2012)

  41. 41.

    , & HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015)

  42. 42.

    et al. INSPEcT: a computational tool to infer mRNA synthesis, processing and degradation dynamics from RNA- and 4sU-seq time course experiments. Bioinformatics 31, 2829–2835 (2015)

  43. 43.

    , & Next maSigPro: updating maSigPro bioconductor package for RNA-seq time series. Bioinformatics 30, 2598–2602 (2014)

Download references


We thank R. Flynn, R. Jackson, Y. Yang, M. Vesely, R. Paiva, N. Palm and all the other members of the Flavell laboratory for discussions and comments. We thank J. Alderman, C. Lieber, C. Hughes and J. Stein for technical support. H.-B.L. was supported by NIH T32 2T32DK007356. S.Z was supported by a fellowship from Helen Hay Whitney Foundation-Howard Hughes Medical Institute. This work was supported by the Howard Hughes Medical Institute (R.A.F.), NSF Major International Joint Research Program of China - 31420103901 (Z.Y. and R.A.F.) and ‘111’ project (Z.Y.), R01-HG004361 (H.Y.C.), NIH New Innovator Award DP2 HD083992-01 (M.D.S.), and a Searle scholarship (M.D.S.).

Author information

Author notes

    • Hua-Bing Li
    • , Jiyu Tong
    •  & Shu Zhu

    These authors contributed equally to this work.

    • Hua-Bing Li
    • , Zhinan Yin
    •  & Richard A. Flavell

    These authors jointly supervised this work.


  1. Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA

    • Hua-Bing Li
    • , Jiyu Tong
    • , Shu Zhu
    • , Jun Zhao
    • , Will Bailis
    • , Guangchao Cao
    • , Lina Kroehling
    • , Yuanyuan Chen
    • , Geng Wang
    •  & Richard A. Flavell
  2. The First Affiliated Hospital, Biomedical Translational Research Institute and Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, Jinan University, Guangzhou 510632, China

    • Jiyu Tong
    • , Guangchao Cao
    •  & Zhinan Yin
  3. Center for Dynamic Regulomes, Stanford University, Stanford, California 94305, USA

    • Pedro J. Batista
    • , James P. Broughton
    • , Y. Grace Chen
    •  & Howard Y. Chang
  4. Department of Molecular Biophysics & Biochemistry, Yale University, New Haven, Connecticut 06511, USA

    • Erin E. Duffy
    •  & Matthew D. Simon
  5. Chemical Biology Institute, Yale University, West Haven, Connecticut 06516, USA

    • Erin E. Duffy
    •  & Matthew D. Simon
  6. Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA

    • Jun Zhao
    •  & Yuval Kluger
  7. Institute of Surgical Research, Daping Hospital, the Third Military Medical University, Chongqing 400038, China

    • Yuanyuan Chen
  8. Howard Hughes Medical Institute, Chevy Chase, Maryland 20815-6789, USA

    • Richard A. Flavell


  1. Search for Hua-Bing Li in:

  2. Search for Jiyu Tong in:

  3. Search for Shu Zhu in:

  4. Search for Pedro J. Batista in:

  5. Search for Erin E. Duffy in:

  6. Search for Jun Zhao in:

  7. Search for Will Bailis in:

  8. Search for Guangchao Cao in:

  9. Search for Lina Kroehling in:

  10. Search for Yuanyuan Chen in:

  11. Search for Geng Wang in:

  12. Search for James P. Broughton in:

  13. Search for Y. Grace Chen in:

  14. Search for Yuval Kluger in:

  15. Search for Matthew D. Simon in:

  16. Search for Howard Y. Chang in:

  17. Search for Zhinan Yin in:

  18. Search for Richard A. Flavell in:


H-B. L. conceived the project. H.-B. L., J. T., S. Z., P.B., E.E.D., W.B., G.C., Y. C., G.W., J.P.B. and Y.G.C. performed the experimental work. J.Z., L.K., M.D.S. and P.B. analysed the RNA-seq, ribo-profiling, s4U-seq and m6A-seq data and performed the statistical analysis. H.Y.C., M.D.S., Y.K., and Z.Y. provided key suggestions. H.-B. L. and R.A.F designed the study, analysed the data and wrote the manuscript. R.A.F. supervised the study.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Hua-Bing Li or Zhinan Yin or Richard A. Flavell.

Reviewer Information Nature thanks F. Fuks, J. H. Hanna and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Supplementary information

PDF files

  1. 1.

    Supplementary information

    This file contains Supplementary Figure 1, the uncropped blots.

  2. 2.

    Reporting Summary

Excel files

  1. 1.

    Supplementary Table 1

    This table contains a list of all the antibodies and reagents used in this study.

  2. 2.

    Supplementary Table 2

    This table contains a list of all the primers used in this study.

  3. 3.

    Supplementary Table 3

    This table contains two lists of up-regulated and down-regulated genes by RNA-Seq of Mettl3 KO and WT Naïve T cells.

  4. 4.

    Supplementary Table 4

    This table contains a list of top 20 up-regulated and down-regulated Ribosome occupancy of Mettl3 KO and WT mRNAs by Ribosome profiling in this study.

  5. 5.

    Supplementary Table 5

    This table contains lists of all the clusters revealed by s4U-Seq of Mettl3 KO and WT naïve T cells in response to IL-7 stimulation over times in this study. Each tab contains one cluster determined by similar time-dependent expression profile changes after IL-7 induction.

About this article

Publication history






Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.